The role of oxygen in regulating microRNAs in control of the placental renin-angiotensin system.


Journal

Molecular human reproduction
ISSN: 1460-2407
Titre abrégé: Mol Hum Reprod
Pays: England
ID NLM: 9513710

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 30 10 2018
revised: 07 01 2019
accepted: 30 01 2019
pubmed: 7 2 2019
medline: 23 5 2020
entrez: 7 2 2019
Statut: ppublish

Résumé

Human placental renin-angiotensin system (RAS) expression is highest in early gestation, at a time when placental oxygen tension is at its lowest (1-3%), and promotes placental development. Some miRNAs predicted to target RAS mRNAs are downregulated in early gestation. We tested the hypothesis that low oxygen suppresses expression of miRNAs that target placental RAS mRNAs, thus increasing concentrations of RAS mRNAs. HTR-8/SVneo cells were cultured in 1, 5 and 20% oxygen for 48 h. Differences in miRNA expression were measured on an Affymetrix miRNA microarray (n = 3/group). Those predicted to target RAS mRNAs, or that were decreased in early gestation, were confirmed by qPCR (n = 9/group). RAS protein levels were assessed by ELISAs or immuno-blotting. Microarray analysis identified four miRNAs predicted to target RAS mRNAs that were differentially expressed between 1 and 5% oxygen. Using qPCR, 15 miRNAs that target the RAS were measured in HTR-8/SVneo cells. Five miRNAs were downregulated in 1% compared with 5% oxygen. Expression of a number of RAS mRNAs (ATP6AP2, AGT, ACE and AGTR1) were increased in either, or both, 1 and 5% oxygen compared with 20% oxygen. AGT protein levels were increased in 1% oxygen compared with 5%. Further validation is needed to confirm that these miRNAs target RAS mRNAs directly and that placental development is partly regulated by oxygen-sensitive miRNAs that target RAS mRNAs. Since placental oxygen tension changes across gestation, changes in expression of these miRNAs may contribute to the transgestational changes in placental RAS expression and the resulting effects on placental development.

Identifiants

pubmed: 30726964
pii: 5307702
doi: 10.1093/molehr/gaz004
doi:

Substances chimiques

AGT protein, human 0
AGTR1 protein, human 0
ATP6AP2 protein, human 0
MicroRNAs 0
RNA, Messenger 0
Receptor, Angiotensin, Type 1 0
Receptors, Cell Surface 0
Angiotensinogen 11002-13-4
ACE protein, human EC 3.4.15.1
Peptidyl-Dipeptidase A EC 3.4.15.1
Vacuolar Proton-Translocating ATPases EC 3.6.1.-
Oxygen S88TT14065

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

206-217

Informations de copyright

© The Author 2019. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Anya L Arthurs (AL)

Priority Research Centre for Reproductive Sciences, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, University Drive, Callaghan, New South Wales, Australia.
Pregnancy and Reproduction, Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights NSW, Australia.

Eugenie R Lumbers (ER)

Priority Research Centre for Reproductive Sciences, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, University Drive, Callaghan, New South Wales, Australia.
Pregnancy and Reproduction, Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights NSW, Australia.

Sarah J Delforce (SJ)

Priority Research Centre for Reproductive Sciences, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, University Drive, Callaghan, New South Wales, Australia.
Pregnancy and Reproduction, Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights NSW, Australia.

Andrea Mathe (A)

School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, University Drive, Callaghan, New South Wales, Australia.

Brian J Morris (BJ)

School of Medical Sciences and Bosch Institute, Anderson Stuart Building, University of Sydney, Camperdown, New South Wales, Australia.

Kirsty G Pringle (KG)

Priority Research Centre for Reproductive Sciences, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, University Drive, Callaghan, New South Wales, Australia.
Pregnancy and Reproduction, Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH